Myomo Inc. (MYO)
Stock Price:
$3.66 USD
0.02 (0.55%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
10.30M |
| Revenue (ttm) |
4.02M |
| Net Income (ttm) |
-11.92M |
| Shares Out |
2.81M |
| EPS (ttm) |
-13.49 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Jul 2, 2020 |
| Last Price |
$3.66 |
| Previous Close |
$3.64 |
| Change ($) |
0.02 |
| Change (%) |
0.55% |
| Day's Open |
3.65 |
| Day's Range |
3.58 - 3.69 |
| Day's Volume |
116,669 |
| 52-Week Range |
2.82 - 40.00 |
More Stats
| Market Cap |
10.30M |
| Enterprise Value |
n/a |
| Earnings Date (est) |
Aug 5, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
2.81M |
| Float |
2.55M |
| EPS (basic) |
-16.759 |
| EPS (diluted) |
-13.49 |
| FCF / Share |
-5.47 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
73,623 |
| Short Ratio |
0.40 |
| Short % of Float |
2.65% |
| Beta |
1.17 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
2.57 |
| PB Ratio |
0.91 |
| Revenue |
4.02M |
| Operating Income |
-11.53M |
| Net Income |
-11.92M |
| Free Cash Flow |
-9.72M |
| Net Cash |
12.37M |
| Net Cash / Share |
4.40 |
| Gross Margin |
72.72% |
| Operating Margin |
-287.23% |
| Profit Margin |
-313.50% |
| FCF Margin |
-242.08% |
| ROA |
-53.38% |
| ROE |
-111.88% |
| ROIC |
-7,609.70% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (3)
| Buy |
2 |
| Overweight |
0 |
| Hold |
1 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$8.50*
(132.24% upside)
Low
5.00
Current: 3.66
High
12.00
Target: 8.50
*Average 12-month price target from 4 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 |
|---|
| Revenue | 3.84 | 2.44 | 1.56 | 1.10 |
| Revenue Growth | 57.02% | 56.79% | 41.29% | - |
| Gross Profit | 2.92 | 1.72 | 1.05 | 0.82 |
| Operating Income | -10.80 | -10.53 | -6.55 | -3.28 |
| Net Income | -10.71 | -10.32 | -12.10 | -3.62 |
| Shares Outstanding | 0.55 | 0.41 | 0.14 | 0.04 |
| Earnings Per Share | -19.35 | -25.18 | -87.96 | -123.91 |
| Operating Cash Flow | -10.34 | -9.61 | -6.15 | -3.20 |
| Capital Expenditures | -0.05 | -0.13 | -0.07 | - |
| Free Cash Flow | -10.39 | -9.73 | -6.22 | -3.20 |
| Cash & Equivalents | 4.54 | 6.62 | 13.01 | 0.85 |
| Total Debt | 2.65 | - | - | 5.45 |
| Net Cash / Debt | 1.89 | 6.62 | 13.01 | -4.61 |
| Assets | 6.60 | 8.28 | 13.97 | 1.66 |
| Liabilities | 4.77 | 1.86 | 1.53 | 6.52 |
| Book Value | 1.82 | 6.43 | 12.45 | -17.53 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Myomo Inc. |
| Country |
United States |
| Employees |
49 |
| CEO |
Paul R. Gudonis |
Stock Information
| Ticker Symbol |
MYO |
| Stock Exchange |
NYSE American |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
NYSEAMERICAN: MYO |
| IPO Date |
June 12, 2017 |
Description
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis used for the purpose of supporting a patient's weak or deformed arm to enable and improve functional activities of daily living, ADLs, in the home and community. Its products are designed to help restore function in individuals with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, rehabilitation hospitals, and through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.